Bank of America Corp. Reiterates Buy Rating for Croda International (CRDA)
Croda International (LON:CRDA)‘s stock had its “buy” rating reaffirmed by analysts at Bank of America Corp. in a research report issued to clients and investors on Thursday, Stock Ratings Network reports. They currently have a GBX 2,870 ($45.97) price target on the stock. Bank of America Corp.’s price objective would suggest a potential upside of 5.59% from the stock’s previous close.
Croda International (LON:CRDA) traded up 0.22% during mid-day trading on Thursday, hitting GBX 2718.00. The stock had a trading volume of 104,770 shares. Croda International has a 1-year low of GBX 1998.0499 and a 1-year high of GBX 2846.00. The stock has a 50-day moving average of GBX 2603.13 and a 200-day moving average of GBX 2569.31. The company’s market cap is £3.672 billion.
CRDA has been the subject of a number of other recent research reports. Analysts at Credit Suisse upgraded shares of Croda International (LON:CRDA) from a “neutral” rating to an “outperform” rating in a research note to investors on Monday. They now have a GBX 3,000 ($48.05) price target on the stock, up previously from GBX 2,600 ($41.65). Separately, analysts at Canaccord Genuity reiterated a “sell” rating on shares of Croda International (LON:CRDA) in a research note to investors on Thursday, September 5th. They now have a GBX 2,000 ($32.04) price target on the stock. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Croda International (LON:CRDA) from GBX 2,820 ($45.17) to GBX 2,850 ($45.65) in a research note to investors on Wednesday, September 4th. They now have an “overweight” rating on the stock. Four investment analysts have rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 2,621.99 ($42.00).
Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.